Pages that link to "Q35871626"
The following pages link to Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. (Q35871626):
Displaying 50 items.
- RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi? (Q26765460) (← links)
- The Rise of CRISPR/Cas for Genome Editing in Stem Cells (Q26765852) (← links)
- CRISPR/Cas9 and cancer targets: future possibilities and present challenges (Q26769907) (← links)
- Strategies for precision modulation of gene expression by epigenome editing: an overview (Q26782876) (← links)
- The CRISPR revolution and its impact on cancer research (Q26824997) (← links)
- Genetically engineered mouse models in oncology research and cancer medicine (Q28079323) (← links)
- CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice (Q33765935) (← links)
- CRISPR/Cas9, a powerful tool to target human herpesviruses (Q34047704) (← links)
- Applications of CRISPR technologies in research and beyond (Q34539796) (← links)
- Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice. (Q36221012) (← links)
- A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice (Q36673956) (← links)
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. (Q36943717) (← links)
- Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland (Q37051766) (← links)
- Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation. (Q37086614) (← links)
- Gene Editing for Treatment of Neurological Infections. (Q37136471) (← links)
- The CRISPR/Cas9 system for gene editing and its potential application in pain research (Q37148023) (← links)
- Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia (Q37237194) (← links)
- A multifunctional AAV-CRISPR-Cas9 and its host response (Q37731772) (← links)
- Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations. (Q38531000) (← links)
- Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery (Q38682882) (← links)
- Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation (Q38700979) (← links)
- Gene editing technology as an approach to the treatment of liver diseases (Q38749884) (← links)
- Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus (Q38770558) (← links)
- Genetic Dissection of Cancer Development, Therapy Response, and Resistance in Mouse Models of Breast Cancer (Q38798405) (← links)
- The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models (Q38836751) (← links)
- The present and future of genome editing in cancer research (Q38840267) (← links)
- Applications of the CRISPR/Cas9 system in murine cancer modeling (Q38858314) (← links)
- CRISPR/Cas9 Flexes Its Muscles: In Vivo Somatic Gene Editing for Muscular Dystrophy (Q38919946) (← links)
- In vivo and in vitro disease modeling with CRISPR/Cas9. (Q38920337) (← links)
- Somatic Engineering of Oncogenic Chromosomal Rearrangements: A Perspective (Q38926441) (← links)
- CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes (Q39014648) (← links)
- Novel AIDS therapies based on gene editing (Q39140209) (← links)
- Delivery technologies for genome editing (Q39197557) (← links)
- Therapeutic gene editing: delivery and regulatory perspectives (Q39230418) (← links)
- The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups (Q39260698) (← links)
- CRISPR/Cas9: at the cutting edge of hepatology. (Q39294371) (← links)
- Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field (Q39319380) (← links)
- CRISPR-Cas based antiviral strategies against HIV-1. (Q40100879) (← links)
- Gene Therapy in Tyrosinemia: Potential and Pitfalls. (Q40103301) (← links)
- CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10. (Q40369908) (← links)
- Somatic Genome Editing Goes Viral (Q40609800) (← links)
- Genome engineering: a new approach to gene therapy for neuromuscular disorders. (Q41928233) (← links)
- CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion (Q42176221) (← links)
- Expression of PTEN-long mediated by CRISPR/Cas9 can repress U87 cell proliferation. (Q45869005) (← links)
- Immunity to CRISPR Cas9 and Cas12a therapeutics (Q45873745) (← links)
- CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes (Q47117286) (← links)
- Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing. (Q47355595) (← links)
- In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease (Q47553772) (← links)
- Break Breast Cancer Addiction by CRISPR/Cas9 Genome Editing (Q47561562) (← links)
- BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance (Q48095662) (← links)